Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1421-1427

  Somani, Jyoti ^a   Bhullar, Vinod B ^b   Workowski, Kimberly A ^a   Farshy, Carol E ^b   Black, Carolyn M ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; OFLOXACIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; HUMAN; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE TRANSMISSION, HORIZONTAL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; URETHRITIS;

EID: 0034105041     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315372     Document Type: Article

References (38)

1. 1. Schachter J, Stoner E, Moncada J. Screening of chlamydial infections in women attending family clinics. West J Med 1983; 138:375-9.
2. 2. Stamm WE, Cole B. Asymptomatic Chlamydia trachomatis urethritis in men. Sex Transm Dis 1986; 13:163-5.
3. 3. Weinstock H, Dean D, Bolan G. Chlamydia trachomatis infections: sexually transmitted diseases in the AIDS era, part II. Infect Dis Clin North Am 1994; 8:797-819.
4. 4. Oriel JD. The carrier state: Chlamydia trachomatis. J Antimicrob Chemother 1986; 18(Suppl A):67-71.
5. 5. Podgore JK, Holmes KK, Alexander ER. Asymptomatic urethral infections due to Chlamydia trachomatis in male U. S. military personnel. J Infect Dis 1982; 146:828.
6. 6. McCormack WM, Alpert S, McComb DE, et al. Fifteen month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 1979; 300:123-5.
7. 7. Parks KS, Dixon PB, Richey CM, Hook EW. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997; 24:229-35.
8. 8. Blythe MJ, Katz BP, Batteiger BE, Ganser JA, Jones RB. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Pediatr 1992; 121:487-93.
9. 9. Munday PE, Thomas BJ, Gilroy CB, Gilchrist C, Taylor-Robinson D. Infrequent detection of Chlamydia trachomatis in a longitudinal study of women with treated cervical infection. Genitourin Med 1995; 71:24-6.
10. 10. Grayston JT, Wang SP. New knowledge of chlamydiae and the diseases they cause. J Infect Dis 1975; 132:87-105.
11. 11. Cotter TW, Miranpuri GS, Ramsey KH, Poulsen CE, Byrne GI. Reactivation of chlamydial genital infection in mice. Infect Immun 1997; 65:2067-73.
12. 12. Dean D, Suchland RJ, Stamm WE. Apparent long term persistence of Chlamydia trachomatis cervical infections: analysis of OMPI genotyping. In: Stephen RS, Byrne GI, Christiansen G, et al., eds. Chlamydial infections. San Francisco: International Chlamydia Symposium, 1998:31-4.
13. 13. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58: 686-99.
14. 14. Theijls H, Gnarpe JG, Lundkvist O, et al. Diagnosis and prevalence of persistent chlamydia infection in infertile women: tissue culture, direct antigen detection, and serology. Fertil Steril 1991; 55:304-10.
15. 15. Campbell LA, Patton DL, Moore DE, Cappuccio AL, Mueller BL, Wang SP. Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril 1993; 59:45-50.
16. 16. Rice RJ, Bhullar V. Mitchell SH, Bullard J, Knapp JS. Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease. Antimicrob Agents Chemother 1995; 39:760-2.
17. 17. Jones RB, Van Der Pol B, Martin DH, Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 1990; 162:1309-15.
18. 18. Johnson RJ, Stamm WE. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 1989; 111:906-17.
19. 19. Ridgeway GL, Owen JM, Oriel JD. A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system. J Antimicrob Chemother 1976; 2:71-6.
20. 20. Beale AS, Masson ND. Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection. J Antimicrob Chemother 1994; 34:1072-5.
21. 21. Wang SP, Grayston JT, Alexander ER, Holmes KK. Simplified immunofluorescence test with trachoma lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol 1975; 1:250-5.
22. 22. Lefevre JC, Lepargneur JP, Guion D, Bei S. Tecycline-resistant Chlamydia trachomatis in Toulouse, France. Pathol Biol 1997; 45:376-8.
23. 23. Mourad A, Sweet RL, Sugg N, Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother 1980; 18: 696-8.
24. 24. Cheema MA, Schumacher HR, Hudson AP. RNA-directed molecular hybridization screening: evidence for inapparent chlamydial infection. Am J Med Sci 1991; 302:261-8.
25. 25. Holland SM, Hudson AP, Bobo L, et al. Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun 1992; 60:2040-7.
26. 26. Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in the Gambia. Scand J Infect Dis Suppl 1990; 69:137-48.
27. 27. Hammerschlag MR, Chirgwin PM, Roblin M, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992; 14:178-82.
28. 28. Roblin PM, Hammerschlag MR. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob Agents Chemother 1998; 42:194-6.
29. 29. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon-gamma mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993; 90:3998-4002.
30. 30. Cunningham DS. Immune response characteristics in women with chlamydial genital tract infection. Gynecol Obstet Invest 1995; 39:54-9.
31. 31. Kunimoto D, Brunham RC. Human immune response to Chlamydia trachomatis infection. Rev Infect Dis 1985; 7:665-73.
32. 32. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-84.
33. 33. Jones RB, Ardery BR, Hui SL, Cleary RE. Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility. Fertil Steril 1982; 38:553-8.
34. 34. Patton DL, Askienazy-Elbhar M, Henry-Suchet J, et al. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 1994; 171:95-101.
35. 35. Chernesky M, Luinstra K, Sellers J, et al. Can serology diagnose upper genital tract Chlamydia trachomatis infection? Sex Transm Dis 1998; 25:14-9.
36. 36. Schachter J, Cles L, Ray R, Hesse FE. Is there immunity to chlamydial infections of the human genital tract? Sex Transm Dis 1983; 10:123-5.
37. 37. Jones RB, Van Der Pol B, Johnson RB. Susceptibility of Chlamydia trachomatis to trovafloxacin. J Antimicrob Chemother 1997; 39(Suppl B): 63-5.
38. 38. Miyashita N, Niki Y, Kishimoto T, Nakajima M, Matsushima T. In vitro and vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother 1997; 41:1331-4.